CBIH Expands Endocannabinoid Research and IP Strategy

Cannabis Bioscience International Holdings announced an expanded research strategy focused on endocannabinoid biology, precision medicine and IP development. It plans to pursue partnerships and licensing related to potential federal cannabis rescheduling.